About 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole
4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole (PubChem CID 161413176) has the molecular formula C83H85N19O4
and a molecular weight of 1412.72 g/mol. Its IUPAC name is 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole.
Frequently Asked Questions
What is the IUPAC name of 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole?
The IUPAC name of 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole (CID 161413176) is 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole.
What is the SMILES notation for 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole?
The canonical SMILES for 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole is Cc1cnccc1-c1cc(-c2c(C)noc2C)cc2[nH]c(C3CC3)nc12.Cc1n[nH]c(C)c1-c1cc(-c2c(C)noc2C)cc2[nH]c(C3CC3)nc12.Cc1n[nH]c(C)c1-c1cc(-c2c(C)noc2C)cc2[nH]c(NCC3CC3)nc12.Cc1ncccc1-c1cc(-c2c(C)noc2C)cc2[nH]c(C3CC3)nc12.
What is the InChIKey of 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole?
The InChIKey is VVSYIINDLYDLTN-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H24N6O.2C21H20N4O.C20H21N5O/c1-10-18(11(2)26-25-10)16-7-15(19-12(3)27-28-13(19)4)8-17-20(16)24-21(23-17)22-9-14-5-6-14;1-11-10-22-7-6-16(11)17-8-15(19-12(2)25-26-13(19)3)9-18-20(17)24-21(23-18)14-4-5-14;1-11-16(5-4-8-22-11)17-9-15(19-12(2)25-26-13(19)3)10-18-20(17)24-21(23-18)14-6-7-14;1-9-17(10(2)24-23-9)15-7-14(18-11(3)25-26-12(18)4)8-16-19(15)22-20(21-16)13-5-6-13/h7-8,14H,5-6,9H2,1-4H3,(H,25,26)(H2,22,23,24);6-10,14H,4-5H2,1-3H3,(H,23,24);4-5,8-10,14H,6-7H2,1-3H3,(H,23,24);7-8,13H,5-6H2,1-4H3,(H,21,22)(H,23,24).
What are the key properties of 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole?
4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole has a molecular weight of 1412.72 g/mol, XLogP of 19.55, 14 rotatable bonds, 7 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-cyclopropyl-7-(3,5-dimethyl-1H-pyrazol-4-yl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;N-(cyclopropylmethyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1H-benzimidazol-2-amine;4-[2-cyclopropyl-7-(2-methyl-3-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole;4-[2-cyclopropyl-7-(3-methyl-4-pyridinyl)-3H-benzimidazol-5-yl]-3,5-dimethyl-1,2-oxazole is sourced from PubChem (CID 161413176), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).